Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Taxes (2024 - 2025)

Agios Pharmaceuticals' Change in Taxes history spans 6 years, with the latest figure at -$683000.0 for Q2 2025.

  • For Q2 2025, Change in Taxes changed N/A year-over-year to -$683000.0; the TTM value through Dec 2025 reached -$871000.0, down 200.0%, while the annual FY2025 figure was -$871000.0, 200.0% down from the prior year.
  • Change in Taxes reached -$683000.0 in Q2 2025 per AGIO's latest filing, down from -$188000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $52.7 million in Q3 2024 to a low of -$51.8 million in Q4 2024.